Related references
Note: Only part of the references are listed.Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model
Chiara Fornari et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Ari Brekkan et al.
AAPS JOURNAL (2018)
Physiologically Based Pharmacokinetic Modeling of Palbociclib
Yanke Yu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
Wan Sun et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
462PA POPULATION PHARMACOKINETIC (PK) ANALYSIS OF PALBOCICLIB (PD-0332991) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
W. Sun et al.
ANNALS OF ONCOLOGY (2017)
Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia
M. Craig
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies
Wenyue Hu et al.
CLINICAL CANCER RESEARCH (2016)
A Mathematical Model of Granulopoiesis Incorporating the Negative Feedback Dynamics and Kinetics of G-CSF/Neutrophil Binding and Internalization
M. Craig et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2016)
A cell-level model of pharmacodynamics-mediated drug disposition
Wojciech Krzyzanski et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2016)
Blood Cell Dynamics: Half of a Century of Modelling
L. Pujo-Menjouet
MATHEMATICAL MODELLING OF NATURAL PHENOMENA (2016)
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
Linking the Cell Cycle to Cell Fate Decisions
Stephen Dalton
TRENDS IN CELL BIOLOGY (2015)
Semimechanistic Cell-Cycle Type-Based Pharmacokinetic/Pharmacodynamic Model of Chemotherapy-Induced Neutropenic Effects of Diflomotecan under Different Dosing Schedules
Victor Mangas-Sanjuan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Modelling chemotherapy effects on granulopoiesis
Sibylle Schirm et al.
BMC SYSTEMS BIOLOGY (2014)
Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling
Angelica L. Quartino et al.
PHARMACEUTICAL RESEARCH (2014)
White blood cell margination in microcirculation
Dmitry A. Fedosov et al.
SOFT MATTER (2014)
What's your age again? Determination of human neutrophil half-lives revisited
Tamar Tak et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Molecular regulation of stem cell quiescence
Tom H. Cheung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Model-Based Approach to Describe G-CSF Effects in Carboplatin-Treated Cancer Patients
Melanie L. Pastor et al.
PHARMACEUTICAL RESEARCH (2013)
Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor
Xiaoyu Yan et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
STAT3 controls myeloid progenitor growth during emergency granulopoiesis
Huiyuan Zhang et al.
BLOOD (2010)
Prediction of Neutropenia-Related Effects of a New Combination Therapy With the Anticancer Drugs BI 2536 (a Plk1 Inhibitor) and Pemetrexed
E. Soto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: Neutrophil alkaline phosphatase activitv as an endorrenous marker
Masako Katoh et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations
Wojciech Krzyzanski et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A Semi-physiological-Based Pharmacokinetic/Pharmacodynamic Model to Describe the Effects of Topotecan on B-Lymphocyte Lineage Cells
Nieves Velez de Mendizabal et al.
PHARMACEUTICAL RESEARCH (2010)
Neutrophil kinetics in health and disease
Charlotte Summers et al.
TRENDS IN IMMUNOLOGY (2010)
Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects
Lorin K. Roskos et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property
Jens M. Nygren et al.
JOURNAL OF IMMUNOLOGY (2006)
Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats
BB Yang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
MJ Banker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomas
JC Panetta et al.
MATHEMATICAL BIOSCIENCES (2003)
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs
LE Friberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Evidence that the number of hematopoietic stem cells per animal is conserved in mammals
JL Abkowitz et al.
BLOOD (2002)
Share Paper
